Compare Cardinal Health Inc (CAH) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs PepsiCo, Inc. — how do they compare? Cardinal Health Inc trades at $228.4 (market cap $53.89B), while PepsiCo, Inc. trades at $136.78 (market cap $184.87B). The key difference: PepsiCo, Inc. is far larger — about 3.4× Cardinal Health Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.37%). Which is the better fit depends on your goals.
| CAH | PEP | |
|---|---|---|
Market Cap | $53.89B | $184.87B |
Sector | Health | Consumer Staples |
52-Week High | $239.71 | $170.44 |
52-Week Low | $146.04 | $133.81 |
Enterprise Value | $58.87B | $227.37B |
Dividend Yield | 0.89% | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
PepsiCo (PEP) trades at $136.03, down 1.78% for the day, with a bearish technical signal and mixed sentiment. The stock shows strong profitability with a 10.78% net margin and 51.59% ROE, though revenue growth remains modest. Recent news highlights price adjustments for snacks after consumer pushback on high costs, while analyst consensus leans Hold with a $159.27 price target.
The outlook is cautious near-term due to technical weakness and pricing challenges, but fundamentals support long-term stability. Risks include competitive pressures and margin compression, while opportunities lie in operational improvements and dividend reliability. Investors should weigh current volatility against the company's solid cash flow and market position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
